\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ and\\ laboratory\\:\\ \ \(0\)\
\-\ pertinent\\ physical\\ findings\\:\\ \\ abdomen\\-\\-distended\\,\\ non\\-tender\\,\\ ascites\\ present\\,\\ no\\ organomegaly\\ detected\\.\\ \\ exam\\ otherwise\\ benign\\.\ \(0\)\
\-\ lab\\ findings\\:\\ \\ chem7\\â\\€\\”141\\/5\\.0\\/105\\/31\\/12\\/0\\.6\\/112\\;\\ cbc\\â\\€\\”8\\.7\\/11\\.0\\/34\\.0\\/181\\;\\ coag\\ pt\\ 12\\.8\\/ptt\\ 27\\.8\\;\\ \ \(0\)\
\-\ lfts\\â\\€\\”alkphos\\ 1052\\/ast\\ 233\\/\\ alt\\ 91\\/\\ tbili\\ 2\\.7\\ \ \(0\)\
\-\ tumor\\ markers\\:\\ ca\\ 27\\-29\\ 1371\\ \\(normal\\ 0\\-37\\)\\,\\ ca\\ 15\\-3\\ 1464\\ \\(normal\\ 0\\-31\\)\\,\\ ca\\ 125\\ 196\\ \\(normal\\ 0\\-34\\)\\,\\ afp\\ normal\ \(0\)\
\-\ histology\\ of\\ breast\\ bx\\:\\ infiltrating\\ ductal\\ ca\\ t3n2m2\ \(0\)\
\-\ histology\\ of\\ liver\\ bx\\:\\ \\ adenocarcinoma\\;\\ special\\ stains\\ include\\ cytokeratin\\ 7\\:\\ positive\\,\\ cytokeratin\\ 20\\:\\ negative\\,\\ progesterone\\/estrogen\\:\\ positive\\,\\ cea\\:\\ focally\\ positive\\,\\ thyroid\\ transcription\\ factor\\ 1\\:\\ negative\\.\ \(0\)\
\-\ treatment\\ and\\ follow\\-up\\:\\ \ \(0\)\
\-\ plan\\ to\\ have\\ pt\\ follow\\-up\\ with\\ pulmonology\\ for\\ assessment\\ of\\ lung\\ function\\ and\\ work\\-up\\ of\\ lung\\ nodules\\.\\ \\ also\\,\\ pt\\ to\\ have\\ colonoscopy\\.\\ \\ consult\\ general\\ surgery\\ placed\\ for\\ evaluation\\ of\\ left\\ breast\\ mass\\.\\ this\\ patient\\ insisted\\ that\\ she\\ be\\ discharged\\ after\\ the\\ diagnostic\\ imaging\\ took\\ place\\ to\\ attend\\ an\\ important\\ family\\ event\\.\\ \\ thus\\,\\ she\\ was\\ discharged\\ on\\ hospital\\ day\\ six\\,\\ with\\ the\\ aforementioned\\ follow\\-up\\ appointments\\ made\\.\ \(0\)\
\-\ image\\ findings\\:\\ \ \(0\)\
\-\ 1\\.\\	pet\\ scan\\â\\€\\”2\\ hypermetabolic\\ foci\\ in\\ left\\ breast\\;\\ focal\\ hypermetabolic\\ uptake\\ in\\ inferior\\ right\\ liver\\ lobe\\ and\\ left\\ liver\\ lobe\\ with\\ diffuse\\/heterogeneous\\ uptake\\ in\\ right\\ lobe\\;\\ diffuse\\ bone\\ uptake\\ in\\ axial\\/appendicular\\ skeleton\\ that\\ is\\ nonspecific\\:\\ \\ malignant\\ vs\\ liver\\ failure\\.\ \(0\)\
\-\ 2\\.\\	mrcp\\/mri\\ abdomen\\â\\€\\”liver\\ cirrhosis\\ and\\ portal\\ htn\\ leading\\ to\\ splenomegaly\\ and\\ ascites\\;\\ no\\ pancreatic\\ ductal\\ dilatation\\;\\ liver\\ lesions\\ are\\ peripheral\\ with\\ capsular\\ retraction\ \(0\)\
\-\ 3\\.\\	ct\\ chest\\â\\€\\”too\\ numerous\\ to\\ count\\ non\\-calcified\\ nodules\\ in\\ lungs\\;\\ left\\ breast\\ lesion\\ and\\ axillary\\ lymph\\ node\ \(0\)\
\-\ 4\\.\\	breast\\ u\\/s\\ \\(image\\ not\\ available\\ for\\ medpix\\)\\ used\\ for\\ core\\ bx\\â\\€\\”1\\.2cm\\ lesion\\ in\\ left\\ upper\\ outer\\ breast\\;\\ birads\\ category\\ 5\ \(0\)\
\-\ diagnosis\\:\\ \\ 64\\ y\\.o\\.\\ female\\ with\\ recurrent\\ breast\\ cancer\\ with\\ metastasis\\ to\\ lymph\\ nodes\\ and\\ lungs\\.\\ \\ liver\\ mass\\ biopsy\\ reveals\\ adenocarcinoma\\,\\ with\\ histology\\ consistent\\ with\\ breast\\ tissue\\.\ \(0\)\
\-\ differential\\ diagnosis\\ for\\ these\\ findings\\ in\\ this\\ case\\:\ \(0\)\
\-\ 1\\.\\	liver\\ lesions\\ and\\ ascites\\:\\ \\ periportal\\ fibrosis\\,\\ cirrhosis\\ leading\\ to\\ hcc\\,\\ regenerating\\ nodules\\,\\ inflammation\\,\\ neoplastic\\ infiltration\\ in\\ interstitium\ \(0\)\
\-\ 2\\.\\	lung\\ nodules\\:\\ \\ metastasis\\,\\ infectious\\,\\ granulomatous\\,\\ tb\\,\\ mycobacterial\ \(0\)\
\-\ 3\\.\\	breast\\ lesions\\:\\ \\ primary\\ lesion\\,\\ metastasis\ \(0\)\
\-\ history\\ \\(can\\ include\\ gestational\\ age\\,\\ or\\ age\\ in\\ days\\,\\ weeks\\,\\ months\\)\\:\ \(0\)\
\-\ 64\\ y\\.o\\.\\ wf\\ with\\ hx\\ of\\ breast\\ ca\\ \\(1996\\)\\,\\ s\\/p\\ lumpectomy\\ and\\ xrt\\,\\ admitted\\ for\\ workup\\ of\\ fatigue\\,\\ 15\\-20\\ lb\\ weight\\ loss\\ in\\ 8\\ months\\,\\ and\\ increased\\ abdominal\\ girth\\ in\\ the\\ setting\\ of\\ imaging\\ studies\\,\\ which\\ show\\ ascites\\ \\(with\\ peritoneal\\ fluid\\ negative\\ for\\ malignant\\ cells\\)\\,\\ liver\\ lesions\\,\\ and\\ multiple\\ lung\\ masses\\.\\ \\ prior\\ workup\\ demonstrated\\ elevated\\ lfts\\,\\ elevated\\ cea\\,\\ ca\\ 19\\-9\\,\\ ca\\ 125\\,\\ and\\ negative\\ viral\\ hepatitis\\ panels\\.\ \(0\)\
\-\ discussion\\ \\(include\\ references\\)\\:\\ \ \(0\)\
\-\ the\\ lung\\ nodules\\ are\\ likely\\ adenocarcinoma\\,\\ which\\ is\\ the\\ most\\ common\\ type\\ of\\ lung\\ cancer\\ in\\ most\\ recently\\ reported\\ series\\,\\ and\\ is\\ the\\ most\\ frequent\\ histologic\\ type\\ in\\ women\\ and\\ nonsmokers\\ of\\ either\\ sex\\.\\ \\ \\ this\\ patient\\ has\\ a\\ 40\\ pack\\ year\\ hx\\ of\\ smoking\\.\\ \\ metastasis\\ is\\ the\\ most\\ common\\ neoplasm\\ in\\ an\\ adult\\ liver\\,\\ and\\ the\\ liver\\ is\\ the\\ second\\ most\\ common\\ site\\ for\\ metastatic\\ spread\\,\\ after\\ the\\ lymph\\ nodes\\.\\ \\ the\\ patient\\ also\\ has\\ recurrent\\ breast\\ cancer\\.\\ \\ infiltrating\\ ductal\\ carcinoma\\ is\\ the\\ most\\ common\\ type\\ of\\ invasive\\ breast\\ cancer\\,\\ accounting\\ for\\ 70\\ to\\ 80\\ percent\\ of\\ invasive\\ lesions\\.\\ \\ \\ the\\ final\\ pathology\\ report\\ indicates\\ that\\ the\\ liver\\ mass\\ is\\ adenocarcinoma\\,\\ with\\ the\\ special\\ stains\\ being\\ consistent\\ with\\ breast\\ tissue\\.\\ \\ the\\ ttf1\\ stain\\ is\\ 70\\-80\\%\\ specific\\ for\\ lung\\ metastasis\\,\\ and\\ it\\ is\\ negative\\ in\\ this\\ case\\.\\ \\ the\\ recurrent\\ breast\\ cancer\\ stage\\ is\\ t3n2m2\\ with\\ metastasis\\ to\\ the\\ liver\\ and\\ presumably\\ lung\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.353496511453224\ \(0\)\
\-\ liver\\:\\ 0\\.3118270894609663\ \(0\)\
\-\ ca\\:\\ 0\\.2076644052988124\ \(0\)\
\-\ lung\\:\\ 0\\.1692132066365069\ \(0\)\
\-\ metastasis\\:\\ 0\\.15290780194136733\ \(0\)\
\-\ ascites\\:\\ 0\\.14346035946531768\ \(0\)\
\-\ nodules\\:\\ 0\\.138138667369389\ \(0\)\
\-\ bx\\:\\ 0\\.1356455933977483\ \(0\)\
\-\ in\\:\\ 0\\.12974874955973772\ \(0\)\
\-\ and\\:\\ 0\\.12933032961182125\ \(0\)\
\-\ the\\:\\ 0\\.12488563255976472\ \(0\)\
\-\ cancer\\:\\ 0\\.11579999454458664\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.11367846355311725\ \(0\)\
\-\ t3n2m2\\:\\ 0\\.11121305832855677\ \(0\)\
\-\ histology\\:\\ 0\\.11071542493724937\ \(0\)\
\-\ most\\:\\ 0\\.10857554269600528\ \(0\)\
\-\ negative\\:\\ 0\\.10763269454247444\ \(0\)\
\-\ for\\:\\ 0\\.10538847975921008\ \(0\)\
\-\ lesions\\:\\ 0\\.09984713297765013\ \(0\)\
\-\ is\\:\\ 0\\.09522296931026963\ \(0\)\
\-\ cytokeratin\\:\\ 0\\.09287678131529997\ \(0\)\
\-\ ductal\\:\\ 0\\.09179631536353747\ \(0\)\
\-\ hypermetabolic\\:\\ 0\\.08936963588280446\ \(0\)\
\-\ with\\:\\ 0\\.08851196223976858\ \(0\)\
\-\ of\\:\\ 0\\.08845910794385077\ \(0\)\
\-\ cea\\:\\ 0\\.08664928254235209\ \(0\)\
\-\ recurrent\\:\\ 0\\.08364130148846816\ \(0\)\
\-\ stains\\:\\ 0\\.08254733396498486\ \(0\)\
\-\ lymph\\:\\ 0\\.08111500575266808\ \(0\)\
\-\ lfts\\:\\ 0\\.0804217837694042\ \(0\)\
\-\ uptake\\:\\ 0\\.08021076643849256\ \(0\)\
\-\ special\\:\\ 0\\.07948354816229694\ \(0\)\
\-\ common\\:\\ 0\\.07887674391444366\ \(0\)\
\-\ to\\:\\ 0\\.07823431889139726\ \(0\)\
\-\ 125\\:\\ 0\\.07703716244549581\ \(0\)\
\-\ pt\\:\\ 0\\.0750707521555895\ \(0\)\
\-\ cirrhosis\\:\\ 0\\.07325604938934904\ \(0\)\
\-\ type\\:\\ 0\\.06997731356176318\ \(0\)\
\-\ positive\\:\\ 0\\.0687370709550084\ \(0\)\
\-\ findings\\:\\ 0\\.06864369378017217\ \(0\)\
\-\ infiltrating\\:\\ 0\\.06822303430016331\ \(0\)\
\-\ workup\\:\\ 0\\.06550268095971094\ \(0\)\
\-\ 64\\:\\ 0\\.06536009399875028\ \(0\)\
\-\ hx\\:\\ 0\\.06327999043990955\ \(0\)\
\-\ invasive\\:\\ 0\\.06327999043990955\ \(0\)\
\-\ include\\:\\ 0\\.06206543093637134\ \(0\)\
\-\ leading\\:\\ 0\\.061817560889194156\ \(0\)\
\-\ lobe\\:\\ 0\\.060282032899078505\ \(0\)\
\-\ discharged\\:\\ 0\\.05968353291428213\ \(0\)\
\-\ left\\:\\ 0\\.05930587145525411\ \(0\)\
\-\ nodes\\:\\ 0\\.059076024144302845\ \(0\)\
\-\ 70\\:\\ 0\\.057416430519544884\ \(0\)\
\-\ normal\\:\\ 0\\.05678719786988539\ \(0\)\
\-\ 1464\\:\\ 0\\.055606529164278384\ \(0\)\
\-\ transcription\\:\\ 0\\.055606529164278384\ \(0\)\
\-\ nonsmokers\\:\\ 0\\.055606529164278384\ \(0\)\
\-\ ttf1\\:\\ 0\\.055606529164278384\ \(0\)\
\-\ 80\\:\\ 0\\.05424638618264704\ \(0\)\
\-\ coag\\:\\ 0\\.05313500723415151\ \(0\)\
\-\ 1371\\:\\ 0\\.05313500723415151\ \(0\)\
\-\ attend\\:\\ 0\\.051381434517903744\ \(0\)\
\-\ lungs\\:\\ 0\\.051322655714664746\ \(0\)\
\-\ 196\\:\\ 0\\.05002125784767757\ \(0\)\
\-\ insisted\\:\\ 0\\.05002125784767757\ \(0\)\
\-\ lesion\\:\\ 0\\.050010090070692535\ \(0\)\
\-\ malignant\\:\\ 0\\.04957213218160599\ \(0\)\
\-\ regenerating\\:\\ 0\\.04890991258777687\ \(0\)\
\-\ panels\\:\\ 0\\.04797028355899395\ \(0\)\
\-\ this\\:\\ 0\\.04779187925409407\ \(0\)\
\-\ elevated\\:\\ 0\\.04740781869045022\ \(0\)\
\-\ birads\\:\\ 0\\.047156339871529104\ \(0\)\
\-\ periportal\\:\\ 0\\.047156339871529104\ \(0\)\
\-\ pulmonology\\:\\ 0\\.046438390657649986\ \(0\)\
\-\ appointments\\:\\ 0\\.046438390657649986\ \(0\)\
\-\ that\\:\\ 0\\.04526803633361497\ \(0\)\
\-\ 20\\:\\ 0\\.04486429264942836\ \(0\)\
\-\ image\\:\\ 0\\.04447476922043042\ \(0\)\
\-\ age\\:\\ 0\\.04365925851395862\ \(0\)\
\-\ diffuse\\:\\ 0\\.04361154398656251\ \(0\)\
\-\ aforementioned\\:\\ 0\\.043324641271176044\ \(0\)\
\-\ interstitium\\:\\ 0\\.043324641271176044\ \(0\)\
\-\ abdomen\\:\\ 0\\.04243230864273354\ \(0\)\
\-\ wf\\:\\ 0\\.042213296011275346\ \(0\)\
\-\ girth\\:\\ 0\\.042213296011275346\ \(0\)\
\-\ mycobacterial\\:\\ 0\\.04188372801541499\ \(0\)\
\-\ lb\\:\\ 0\\.04188372801541499\ \(0\)\
\-\ sex\\:\\ 0\\.04188372801541499\ \(0\)\
\-\ she\\:\\ 0\\.04139679293053064\ \(0\)\
\-\ accounting\\:\\ 0\\.04127366698249243\ \(0\)\
\-\ focally\\:\\ 0\\.04071914640757254\ \(0\)\
\-\ capsular\\:\\ 0\\.04071914640757254\ \(0\)\
\-\ months\\:\\ 0\\.04047916523060316\ \(0\)\
\-\ splenomegaly\\:\\ 0\\.04045972329502758\ \(0\)\
\-\ presumably\\:\\ 0\\.04045972329502758\ \(0\)\
\-\ tbili\\:\\ 0\\.0402108918847021\ \(0\)\
\-\ markers\\:\\ 0\\.0402108918847021\ \(0\)\
\-\ hcc\\:\\ 0\\.0402108918847021\ \(0\)\
\-\ lumpectomy\\:\\ 0\\.0402108918847021\ \(0\)\
\-\ took\\:\\ 0\\.039971821121928375\ \(0\)\
\-\ category\\:\\ 0\\.039971821121928375\ \(0\)\
\-\ xrt\\:\\ 0\\.039971821121928375\ \(0\)\
\-\ mass\\:\\ 0\\.03984487484734976\ \(0\)\
\-\ organomegaly\\:\\ 0\\.039099546624801404\ \(0\)\
\-\ histologic\\:\\ 0\\.03889967550254844\ \(0\)\
\-\ retraction\\:\\ 0\\.038706150578779824\ \(0\)\
\-\ plan\\:\\ 0\\.037821190284995795\ \(0\)\
\-\ skeleton\\:\\ 0\\.037821190284995795\ \(0\)\
\-\ stain\\:\\ 0\\.037821190284995795\ \(0\)\
\-\ physical\\:\\ 0\\.03770735729262579\ \(0\)\
\-\ consistent\\:\\ 0\\.03770735729262579\ \(0\)\
\-\ 1996\\:\\ 0\\.03765863336904035\ \(0\)\
\-\ afp\\:\\ 0\\.03662802469467452\ \(0\)\
\-\ consult\\:\\ 0\\.03662802469467452\ \(0\)\
\-\ indicates\\:\\ 0\\.03662802469467452\ \(0\)\
\-\ imaging\\:\\ 0\\.03654676022805157\ \(0\)\
\-\ tissue\\:\\ 0\\.036480251355034195\ \(0\)\
\-\ colonoscopy\\:\\ 0\\.03623462864865294\ \(0\)\
\-\ pack\\:\\ 0\\.03610894330733486\ \(0\)\
\-\ diagnosis\\:\\ 0\\.03605016450409586\ \(0\)\
\-\ hepatitis\\:\\ 0\\.03574672647555373\ \(0\)\
\-\ pertinent\\:\\ 0\\.035294999619870024\ \(0\)\
\-\ exam\\:\\ 0\\.035007559737679585\ \(0\)\
\-\ case\\:\\ 0\\.03493722658382585\ \(0\)\
\-\ core\\:\\ 0\\.03487445197842676\ \(0\)\
\-\ have\\:\\ 0\\.03474012501498701\ \(0\)\
\-\ event\\:\\ 0\\.0346745808561738\ \(0\)\
\-\ htn\\:\\ 0\\.0346745808561738\ \(0\)\
\-\ percent\\:\\ 0\\.03438654980532755\ \(0\)\
\-\ infiltration\\:\\ 0\\.03429348657637326\ \(0\)\
\-\ axillary\\:\\ 0\\.03420182284761881\ \(0\)\
\-\ final\\:\\ 0\\.034111517150081656\ \(0\)\
\-\ assessment\\:\\ 0\\.03402252983107102\ \(0\)\
\-\ patient\\:\\ 0\\.03392786188967198\ \(0\)\
\-\ gestational\\:\\ 0\\.033763106718526066\ \(0\)\
\-\ after\\:\\ 0\\.03373604336718691\ \(0\)\
\-\ medpix\\:\\ 0\\.03367902920493079\ \(0\)\
\-\ fatigue\\:\\ 0\\.03367902920493079\ \(0\)\
\-\ alt\\:\\ 0\\.03343353872266571\ \(0\)\
\-\ outer\\:\\ 0\\.03343353872266571\ \(0\)\
\-\ detected\\:\\ 0\\.03335385754759034\ \(0\)\
\-\ portal\\:\\ 0\\.03327520454542685\ \(0\)\
\-\ also\\:\\ 0\\.032710640538767724\ \(0\)\
\-\ nonspecific\\:\\ 0\\.03268004699937514\ \(0\)\
\-\ peritoneal\\:\\ 0\\.03268004699937514\ \(0\)\
\-\ factor\\:\\ 0\\.03260957773944825\ \(0\)\
\-\ setting\\:\\ 0\\.03233557551664393\ \(0\)\
\-\ pet\\:\\ 0\\.03220305892604692\ \(0\)\
\-\ smoking\\:\\ 0\\.03220305892604692\ \(0\)\
\-\ neoplastic\\:\\ 0\\.03213786554424293\ \(0\)\
\-\ viral\\:\\ 0\\.032073362052439526\ \(0\)\
\-\ adult\\:\\ 0\\.032073362052439526\ \(0\)\
\-\ thus\\:\\ 0\\.031946367394588955\ \(0\)\
\-\ series\\:\\ 0\\.03188384866096022\ \(0\)\
\-\ frequent\\:\\ 0\\.03188384866096022\ \(0\)\
\-\ has\\:\\ 0\\.031764833860724616\ \(0\)\
\-\ which\\:\\ 0\\.03162151351867712\ \(0\)\
\-\ pancreatic\\:\\ 0\\.03152163182917909\ \(0\)\
\-\ lab\\:\\ 0\\.03140552311684361\ \(0\)\
\-\ place\\:\\ 0\\.031348287737698155\ \(0\)\
\-\ women\\:\\ 0\\.031291584788399184\ \(0\)\
\-\ six\\:\\ 0\\.03123540445436127\ \(0\)\
\-\ spread\\:\\ 0\\.03123540445436127\ \(0\)\
\-\ tb\\:\\ 0\\.03096201679253883\ \(0\)\
\-\ granulomatous\\:\\ 0\\.030908780444597078\ \(0\)\
\-\ discussion\\:\\ 0\\.03044948620979916\ \(0\)\
\-\ recently\\:\\ 0\\.030351955759616266\ \(0\)\
\-\ node\\:\\ 0\\.029886422503707013\ \(0\)\
\-\ distended\\:\\ 0\\.0297097283032692\ \(0\)\
\-\ important\\:\\ 0\\.029453934558556147\ \(0\)\
\-\ numerous\\:\\ 0\\.029371000992246512\ \(0\)\
\-\ report\\:\\ 0\\.029289180661825936\ \(0\)\
\-\ fibrosis\\:\\ 0\\.029128762901215702\ \(0\)\
\-\ either\\:\\ 0\\.028745270225518153\ \(0\)\
\-\ count\\:\\ 0\\.028708215259772442\ \(0\)\
\-\ admitted\\:\\ 0\\.028490494862411953\ \(0\)\
\-\ foci\\:\\ 0\\.028419615888279313\ \(0\)\
\-\ dilatation\\:\\ 0\\.028384483093073603\ \(0\)\
\-\ function\\:\\ 0\\.028144065104502906\ \(0\)\
\-\ site\\:\\ 0\\.02804386246844862\ \(0\)\
\-\ infectious\\:\\ 0\\.02797796427967228\ \(0\)\
\-\ inflammation\\:\\ 0\\.027945280431427334\ \(0\)\
\-\ general\\:\\ 0\\.027912770897868294\ \(0\)\
\-\ references\\:\\ 0\\.02772127274821431\ \(0\)\
\-\ stage\\:\\ 0\\.027689933228826024\ \(0\)\
\-\ family\\:\\ 0\\.027355431583895348\ \(0\)\
\-\ thyroid\\:\\ 0\\.027325913254569505\ \(0\)\
\-\ pathology\\:\\ 0\\.027296537182804444\ \(0\)\
\-\ placed\\:\\ 0\\.02709477568277432\ \(0\)\
\-\ made\\:\\ 0\\.02681765873169906\ \(0\)\
\-\ cells\\:\\ 0\\.02679062754286102\ \(0\)\
\-\ an\\:\\ 0\\.026592689772929376\ \(0\)\
\-\ vs\\:\\ 0\\.026526710863512035\ \(0\)\
\-\ diagnostic\\:\\ 0\\.0265009369431089\ \(0\)\
\-\ reveals\\:\\ 0\\.026449713758534464\ \(0\)\
\-\ failure\\:\\ 0\\.026398917438792826\ \(0\)\
\-\ are\\:\\ 0\\.02638808817532522\ \(0\)\
\-\ specific\\:\\ 0\\.02634854092814543\ \(0\)\
\-\ used\\:\\ 0\\.0260308666396559\ \(0\)\
\-\ second\\:\\ 0\\.0260308666396559\ \(0\)\
\-\ hospital\\:\\ 0\\.02568377916482684\ \(0\)\
\-\ 40\\:\\ 0\\.025572340538321737\ \(0\)\
\-\ studies\\:\\ 0\\.025506442349545397\ \(0\)\
\-\ laboratory\\:\\ 0\\.025249750818087432\ \(0\)\
\-\ reported\\:\\ 0\\.025043801394090705\ \(0\)\
\-\ peripheral\\:\\ 0\\.024864214893198334\ \(0\)\
\-\ otherwise\\:\\ 0\\.024786066090802996\ \(0\)\
\-\ biopsy\\:\\ 0\\.02437328839699386\ \(0\)\
\-\ weight\\:\\ 0\\.024247603055675783\ \(0\)\
\-\ being\\:\\ 0\\.024229857706625862\ \(0\)\
\-\ benign\\:\\ 0\\.023885386223894647\ \(0\)\
\-\ neoplasm\\:\\ 0\\.023736505803084416\ \(0\)\
\-\ masses\\:\\ 0\\.023671486273599756\ \(0\)\
\-\ inferior\\:\\ 0\\.023655339183114743\ \(0\)\
\-\ available\\:\\ 0\\.02359117518965967\ \(0\)\
\-\ right\\:\\ 0\\.02305610446573765\ \(0\)\
\-\ no\\:\\ 0\\.022614320171090243\ \(0\)\
\-\ differential\\:\\ 0\\.022592564085324413\ \(0\)\
\-\ day\\:\\ 0\\.022148582495096537\ \(0\)\
\-\ show\\:\\ 0\\.022073482697984755\ \(0\)\
\-\ days\\:\\ 0\\.022011598683270916\ \(0\)\
\-\ primary\\:\\ 0\\.021380464083658842\ \(0\)\
\-\ demonstrated\\:\\ 0\\.02136937122692385\ \(0\)\
\-\ evaluation\\:\\ 0\\.021205356226260196\ \(0\)\
\-\ loss\\:\\ 0\\.02118381725298786\ \(0\)\
\-\ weeks\\:\\ 0\\.020838991369076652\ \(0\)\
\-\ focal\\:\\ 0\\.020798489405488525\ \(0\)\
\-\ carcinoma\\:\\ 0\\.020798489405488525\ \(0\)\
\-\ likely\\:\\ 0\\.020778338897572097\ \(0\)\
\-\ fluid\\:\\ 0\\.020076056540731548\ \(0\)\
\-\ these\\:\\ 0\\.019635224277927694\ \(0\)\
\-\ prior\\:\\ 0\\.019454481241011817\ \(0\)\
\-\ metastatic\\:\\ 0\\.019070198861916424\ \(0\)\
\-\ abdominal\\:\\ 0\\.0190172268815461\ \(0\)\
\-\ bone\\:\\ 0\\.018972185865573237\ \(0\)\
\-\ increased\\:\\ 0\\.018802547535649472\ \(0\)\
\-\ surgery\\:\\ 0\\.018694404135688403\ \(0\)\
\-\ upper\\:\\ 0\\.018581127508206813\ \(0\)\
\-\ can\\:\\ 0\\.018246762066951736\ \(0\)\
\-\ tumor\\:\\ 0\\.018187293077266953\ \(0\)\
\-\ present\\:\\ 0\\.017842171301358227\ \(0\)\
\-\ it\\:\\ 0\\.017798830680315694\ \(0\)\
\-\ multiple\\:\\ 0\\.017007292768723592\ \(0\)\
\-\ female\\:\\ 0\\.016778650619432227\ \(0\)\
\-\ treatment\\:\\ 0\\.016563311178495712\ \(0\)\
\-\ be\\:\\ 0\\.014105237732795118\ \(0\)\
\-\ not\\:\\ 0\\.013726795898231984\ \(0\)\
\-\ history\\:\\ 0\\.013284566094212788\ \(0\)\
\-\ ct\\:\\ 0\\.013237677223822802\ \(0\)\
\-\ was\\:\\ 0\\.012118066187312173\ \(0\)\
\-\ or\\:\\ 0\\.012096240141377676\ \(0\)\
\-\ year\\:\\ 0\\.01071576276489768\ \(0\)\
\-\ on\\:\\ 0\\.010501463479137649\ \(0\)\
